Table 1 Antimicrobial and anticancer screening results of synthesized compounds
From: Bis-pyrimidine acetamides: design, synthesis and biological evaluation
Compounds No. | Minimum inhibitory concentration (MIC = µmol/mL) | IC50 (µmol/mL) Cancer cell line | ||||||
|---|---|---|---|---|---|---|---|---|
Bacterial species | Fungal species | |||||||
Gram positive | Gram negative | |||||||
S. aureus MTCC-3160 | B. subtilis MTCC-441 | P. aeruginosa MTCC-3542 | S. enterica MTCC-1165 | E. coli MTCC-443 | C. albicans MTCC-227 | A. niger MTCC-281 | HCT-116 | |
1. | 0.72 | 0.36 | 1.45 | 0.72 | 1.45 | 1.45 | 1.45 | 3.86 |
2. | 0.72 | 0.72 | 0.72 | 0.72 | 1.45 | 0.72 | 1.45 | 3.86 |
3. | 1.31 | 0.33 | 0.66 | 0.66 | 1.31 | 0.66 | 1.31 | 3.50 |
4. | 0.75 | 0.19 | 0.75 | 0.75 | 1.50 | 0.75 | 1.50 | 4.00 |
5. | 0.78 | 0.78 | 0.78 | 1.56 | 1.56 | 0.78 | 1.56 | 4.16 |
6. | 0.74 | 0.37 | 0.74 | 1.48 | 1.48 | 1.48 | 1.48 | 3.96 |
7. | 0.67 | 0.67 | 1.34 | 0.67 | 1.34 | 1.34 | 1.34 | 3.58 |
8. | 0.72 | 1.45 | 1.45 | 0.72 | 1.45 | 0.72 | 1.45 | 3.86 |
9. | 0.74 | 0.74 | 0.74 | 1.48 | 1.48 | 0.74 | 1.48 | 1.98 |
10. | 0.74 | 0.19 | 0.74 | 1.48 | 1.48 | 0.74 | 1.48 | 3.96 |
11. | 0.39 | 0.39 | 0.77 | 0.77 | 0.77 | 0.77 | 1.55 | 1.52 |
12. | 0.39 | 0.39 | 0.77 | 0.77 | 1.55 | 0.77 | 1.55 | 0.74 |
13. | 0.17 | 0.34 | 0.67 | 0.67 | 1.34 | 0.67 | 1.34 | 3.58 |
14. | 1.51 | 0.75 | 0.38 | 1.51 | 1.51 | 0.75 | 1.51 | 4.02 |
15. | 0.38 | 0.38 | 0.75 | 0.75 | 0.75 | 0.75 | 1.51 | 2.17 |
16. | 0.17 | 0.17 | 0.34 | 0.67 | 0.67 | 0.67 | 1.34 | 0.98 |
17. | 0.17 | 0.34 | 0.34 | 0.69 | 1.37 | 0.69 | 1.37 | 1.22 |
18. | 0.34 | 0.69 | 0.69 | 0.69 | 1.37 | 0.34 | 1.37 | 0.73 |
19. | 0.75 | 0.38 | 0.75 | 0.75 | 1.50 | 0.75 | 1.50 | 4.00 |
20. | 0.19 | 0.38 | 0.75 | 0.75 | 1.50 | 0.75 | 1.50 | 2.16 |
DMSO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – |
Cefadroxil | 1.72 | 0.86 | 1.72 | 1.72 | 1.72 | – | – | – |
Fluconazole | – | – | – | – | – | 1.02 | 2.04 | – |
5-Fluorouracil | – | – | – | – | – | – | – | 7.67 |